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Copper is an essential yet toxic metal and its over-
load causes Wilson disease, a disorder due to
mutations in copper transporter ATP7B. To remove
excess copper into the bile, ATP7B traffics toward
canalicular area of hepatocytes. However, the traf-
ficking mechanisms of ATP7B remain elusive. Here,
we show that, in response to elevated copper,
ATP7B moves from the Golgi to lysosomes and im-
ports metal into their lumen. ATP7B enables lyso-
somes to undergo exocytosis through the interaction
with p62 subunit of dynactin that allows lysosome
translocation toward the canalicular pole of hepato-
cytes. Activation of lysosomal exocytosis stimulates
copper clearance from the hepatocytes and rescues
the most frequent Wilson-disease-causing ATP7B
mutant to the appropriate functional site. Our find-
ings indicate that lysosomes serve as an important
intermediate in ATP7B trafficking, whereas lyso-
somal exocytosis operates as an integral process in
copper excretion and hence can be targeted for ther-
apeutic approaches to combat Wilson disease.
INTRODUCTION
Copper is an indispensable micronutrient because a number of
enzymes require it as a cofactor for fundamental metabolic pro-
cesses such as respiration; free radical scavenging; pigmenta-
tion; and synthesis of collagen, elastin, and neurotransmitters
(Lutsenko, 2010; Nevitt et al., 2012). However, due to its redox
potential, copper can induce cellular toxicity. To avoid toxic
accumulation of Cu, vertebrates developed a fine-tuned mecha-686 Developmental Cell 29, 686–700, June 23, 2014 ª2014 The Authnism that allows excess Cu to be removed from the organism
through the Cu-transporting ATPase ATP7B. ATP7B is a large
multidomain protein with eight transmembrane helices, which
form a channel that pumps Cu from the cytosol at the expense
of ATP hydrolysis (Figure 1A). ATP7B is highly expressed in liver,
where it normally resides in the trans-Golgi network (TGN) of
hepatocytes and loads Cu on newly synthetized ceruloplasmin,
the major Cu-carrying protein in the blood (Lutsenko, 2010).
When intracellular Cu levels increase, ATP7B is thought to traffic
toward the biliary surface of hepatocytes and associated ‘‘vesi-
cles’’ involved in the excretion of Cu into bile. Mutations in the
ATP7B gene frequently result in the failure of its protein product
to traffic to the sites of Cu excretion. This defect causes toxic
accumulation of Cu in the liver and, as a consequence, develop-
ment of Wilson disease that is fatal if not treated in time (Gupta
and Lutsenko, 2009).
Despite the fundamental role of ATP7B trafficking in Cu
homeostasis, the intracellular itinerary of ATP7B transport re-
mains poorly understood and controversial (La Fontaine and
Mercer, 2007; Polishchuk and Lutsenko, 2013). First, in contrast
to common view, several studies conducted in hepatic cells indi-
cate that Cu does not alter the intracellular distribution of ATP7B
(Harada et al., 2000, 2005). Second, the uncertainty in ATP7B
trafficking concerns the identity of the peripheral vesicular struc-
tures, whose ability to receive ATP7B upon Cu overload was
associatedwith aCu excretion process (La Fontaine andMercer,
2007; Polishchuk and Lutsenko, 2013). The majority of studies
failed to demonstrate any significant overlap between ATP7B
vesicles and common exo- or endocytic markers (Guo et al.,
2005; La Fontaine et al., 2001), whereas few publications re-
ported a fluorescent ATP7B fusion protein within the late endo-
some compartment (Harada et al., 2000, 2005). Therefore, the
simple term ‘‘vesicles’’ is often applied to ATP7B-positive struc-
tures because lack of coherent data identifying their molecular
composition and ultrastructure makes it problematic to classify
them as specific exo- or endocytic organelles. Finally, theors
Figure 1. Increasing Cu Concentration Triggers ATP7B Trafficking from the TGN to LE/Lysosome Compartments
(A) Schematic structure of ATP7B. Black balls show N-terminal metal-binding domains. Numbers indicate transmembrane helices. The domains, which regulate
ATPase activity, are indicated in italic with D residue for catalytic phosphorylation and with most frequent WD-causing mutation, H1069Q (yellow star).
(B) HepG2 cells were fixed after overnight exposure to 200 mM BCS and stained for endogenous ATP7B and golgin 97.
(C) BCS-treated cells were washed and incubated with 200 mMCuSO4 for 2 hr. Confocal microscopy reveals endogenous ATP7B in vacuolar structures (arrows),
which did not contain Golgin 97 or EEA1 but were decorated by LAMP1.
(D) Quantification shows ATP7B colocalization (mean ± SD; n = 50 cells) with lysosomal markers.
(E) Percentage (mean ± SD; n = 20 fields) of the cells with ATP7B in the TGN or in the lysosomes was calculated for treatments with BCS or with different
concentration of CuSO4 (as indicated along x axis).
(F and G) HepG2 cells were infected with adenovirus carrying ATP7B-GFP (adeno-ATP7B-GFP) and incubated with BCS. Then, the cells were fixed either directly
(F) or after 2 hr incubation with CuSO4 (G) and immunogold labeled to reveal ATP7B-GFP. Arrows indicate ATP7B signal over the TGNmembranes in low Cu (F) or
over the MVB/lysosome-like structures (G) in elevated Cu. Arrowheads show ATP7B at the cell surface in cells exposed to CuSO4 (G).
(H) Pie plots exhibit percentage of ATP7B-associated gold particles in different compartments in cells treated with BCS or CuSO4. EE, early endosome.
The scale bars represent 5 mm (B and C) or 250 nm (F and G).
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ATP7B-Driven Lysosome Exocytosis in Cu Homeostasisquestion on whether or not ATP7B really reaches the canalicular
surface of hepatocytes became the issue of ongoing debate
(Hubbard and Braiterman, 2008).
As a consequence of above gaps in understanding of ATP7B
trafficking, it is yet to be determined (1) which transport route
is employed by ATP7B to reach ‘‘vesicles’’ and from where it
emerges, (2) whether and how ATP7B gets delivered from ‘‘ves-
icles’’ to the canalicular surface of hepatocytes, and (3) how
ATP7B trafficking is coordinated with Cu excretion from the cell.
Here, we show that an increase in Cu concentration induces
direct ATP7B trafficking from the TGN to a subset of lysosomes,
where ATP7B imports Cu for storage in the lysosome lumen and
through the interaction with p62 subunit of dynactin complex
enables lysosomes for polarized exocytosis at the canalicular
surface of hepatocytes. Activation of lysosomal exocytosis
stimulates both the delivery of ATP7B and its Wilson-disease-
causing mutant to the canalicular membrane domains of hepa-
tocytes and the release of excess Cu into the bile. Thus, our
findings indicate ATP7B-containing lysosomes and lysosomal
exocytosis as key components of Cu homeostasis.
RESULTS
Cu Induces ATP7B Redistribution from the TGN to Late-
Endosome/Lysosome Compartments
We first investigated trafficking and localization of ATP7B in hep-
atoma HepG2 cells under different conditions varying in Cu
levels. HepG2 cells express endogenous ATP7B and maintain
key properties of normal hepatocytes, representing a reliable
system to investigate trafficking of human ATP7B (Cater et al.,
2006; Roelofsen et al., 2000). Figure 1B shows that Cu chelation
with bathocuproine disulphonate (BCS) resulted in ATP7B accu-
mulation in the Golgi region, where ATP7B colocalized with the
TGN marker golgin-97. To stimulate ATP7B trafficking from the
TGN, BCS-treated cells were washed and exposed to 200 mM
CuSO4 for 2 hr. This resulted in complete loss of the ATP7B
from the TGN and its relocation to peripheral vesicular structures
(Figure 1C, arrows). To determine whether these structures
belong to an annotated exo- or endocytic compartment, we
tested a battery of markers for overlap with the endogenous
ATP7B. Confocal microscopy revealed significant colocalization
between ATP7B and the late-endosome (LE)/lysosome markers
LAMP1, CD63, and LBPA in the vesicular structures (Figures 1C
and 1D and Figure S1A available online). In addition, we analyzed
the distribution of the S340A mutant of ATP7B, which constantly
resides in ‘‘vesicular’’ compartments (Hasan et al., 2012), and
found its robust overlap with LAMP1 (Figure S1B). These obser-
vations suggest that ATP7B traffics from the TGN to the LE/lyso-
some compartment in response to elevated Cu. This process
was extremely sensitive to Cu. Even relatively low (5–20 mM)
Cu concentration induced ATP7B trafficking to LE/lysosomes
(Figure 1E). Importantly, we also found LAMP1-, CD63-, and
LBPA-positive organelles without ATP7B signal, indicating that
only a subset (about 40%) of the LE/lysosomes received
ATP7B from the TGN (Figure S1C).
To further verify LE/lysosomal targeting of ATP7B, we em-
ployed immuno-electron microscopy (EM) analysis of ATP7B-
GFP that exhibited trafficking and localization similar to the
endogenous ATP7B (Figure S1D). In response to Cu, ATP7B-688 Developmental Cell 29, 686–700, June 23, 2014 ª2014 The AuthGFP moved from the tubular-vesicular TGN membranes (Fig-
ure 1F, arrows) to large multivesicular body (MVB)-like structures
(Figure 1G, arrows; see also morphometry in Figure 1H), which
contained numerous intraluminal vesicles (ILVs) and/or hetero-
geneous electron dense material (Figures 2A and 2B). These
ultrastructural features allowed us to assign ATP7B-containing
organelles to the LE/lysosome compartment (Saftig and Klum-
perman, 2009). Indeed, a double immunogold labeling revealed
ATP7B-positive MVBs to contain LAMP1 (Figure 2B). Finally,
we verified whether ATP7B is also transported to LE/lysosomal
structures in vivo. Thin sections of mice liver revealed ATP7B-
GFP (expressed via adenoviral vector) in MVB-like structures
decorated by LAMP1 (Figure 2C) and similar to those observed
in HepG2 cells. Therefore, ATP7B ‘‘vesicles’’ in the HepG2 line
and in mouse hepatocytes can be defined as LE/lysosomes
from both molecular and ultrastructural standpoints (for con-
venience, we will call them ‘‘lysosomes’’ through the rest of the
manuscript).
Lysosomal localization of ATP7B prompted us to investigate
whether the protein is directed to lysosomes for degradation
that requires sorting into ILVs located in the lumen of lysosomes
(Saftig and Klumperman, 2009). We found that only a small frac-
tion of ATP7B was associated with ILVs and lysosome lumen
(Figures 2A–2E), even when compared to LAMP1 (Figures 2A
and 2E). Correspondingly, ATP7B levels remained unaffected
when lysosome degradation was inhibited with bafilomycin A
(Figure S2), indicating that ATP7B is targeted to lysosomes to
perform a specific function at their limiting membranes, but not
to be degraded.
ATP7B Is Transported to the Lysosomal Compartment
through a Direct Route that Emerges from the TGN
In response to Cu, ATP7B may travel via two possible routes: (1)
it may first be delivered from the TGN to the cell surface and then
be endocytosed to the lysosomes (indirect pathway) or (2)
ATP7B might be conveyed from the TGN directly to the lyso-
somal compartments (direct pathway). To distinguish between
these two possibilities, we treated HepG2 cells with tannic acid
(TA), which blocks both the exo- and endocytic events at the
level of the plasma membrane (Polishchuk et al., 2004). This
treatment would prevent ATP7B trafficking to the lysosomes
through the indirect pathway but would not impact the direct
route. As a control, HepG2 cells were infected with the vesicular
stomatitis virus (VSV) to express a thermosensitive t-45Os
version of VSV glycoprotein (VSVG), a bona fide exocytic marker
(Polishchuk et al., 2003). The cells were incubated at 20C with
BCS to accumulate both VSVG and ATP7B within the Golgi (Fig-
ure 2F). Cells were then shifted to 32C in the presence of CuSO4
to activate both VSVG and ATP7B export from the TGN. In the
absence of TA, VSVG was delivered from the TGN to the cell
surface, whereas TA treatment caused VSVG arrest within
TGN-derived transport carriers, which were docked at the
plasma membrane (PM) but unable to fuse with acceptor mem-
brane (Figure 2F). In contrast, accumulation of ATP7B within
such post-Golgi VSVG-positive carries did not occur. Instead,
most of ATP7B appeared within larger lysosome-like structures
both in control and TA-treated cells (Figure 2F), indicating that
ATP7B traffics directly from the TGN to lysosomes in response
to an increase in Cu concentration.ors
Figure 2. Lysosomes Retain ATP7B at Their
Limiting Membranes and Receive ATP7B
from the TGN through a Direct Route
(A) CuSO4-treated HepG2 cells were immunogold
labeled to reveal either ATP7B-GFP or LAMP1.
Arrows in top panel indicate ATP7B distribution
along limiting membrane of the MVBs, whereas
some LAMP1 labeling can be seen at the internal
membranes of lysosomes (arrow in bottom panel).
(B) CuSO4-treated HepG2 cells were processed
for cryo-immuno-EM. Arrows and arrowheads
indicate ATP7B-GFP and LAMP1, respectively,
within the same lysosome-like structures.
(C) Liver tissue from mice, which was injected with
adeno-ATP7B-GFP and treated with CuSO4, was
labeled for ATP7B-GFP and LAMP1. ATP7B-GFP
(arrows) and LAMP1 (arrowheads) were detected
together within lysosome-like structures.
(D) Quantification of the percentage of gold parti-
cles in lysosomes (mean ± SD; n = 100 structures)
shows most of ATP7B to reside at the external
membrane.
(E) CuSO4-treated HepG2 cells exhibit endoge-
nous ATP7B as circles (arrows) at the surface of
LAMP1-positive structures.
(F) HepG2 cells were infected with VSV (see
Experimental Procedures) and fixed directly after
20C block (left panel) or incubated at 32C with
CuSO4 for 60 min with (right panel) or without
(midpanel) tannic acid (TA). Empty arrows indicate
VSVG at the cell surface (midpanel) and post-Golgi
carriers (right panel), whereas filled arrows indicate
lysosome-like ATP7B structures.
(G) HepG2 cells were fixed directly after incubation
with BCS or exposed to CuSO4 for either 15 min or
60 min and stained for endogenous ATP7B and
LAMP1. Arrows indicate ATP7B/LAMP1-positive
structures.
(H and I) HepG2 cells expressing ATP7B-GFP
were incubated with BCS and fixed directly (H) or
15 min after incubation with CuSO4 (I) and labeled
for ATP7B-GFP and LAMP1. ATP7B and LAMP1
were detected in some TGN domains (H, arrows) of
the Golgi stack (H, asterisk). Arrow in (I) indicates
ATP7B/LAMP1 post-Golgi carrier near the ATP7B/
LAMP1-positive MVBs (arrowheads).
The scale bars represent 250 nm (A), 150 nm (B, C,
H, and I), 3.5 mm (E and F), and 7 mm (G).
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ATP7B-Driven Lysosome Exocytosis in Cu HomeostasisTo further verify this conclusion, we performed a time course
analysis of ATP7B release from the TGN. As soon as 15 min after
Cu addition, the ATP7B signal was detected in LAMP1-positiveDevelopmental Cell 29, 686–7structures (Figure 2G, arrows). Such a
fast rate of ATP7B trafficking argues
against the indirect pathway because
the uptake from the PM to lysosomes
alone usually takes at least 30 min (Saftig
and Klumperman, 2009). In addition, no
ATP7B was observed at the surface of
hepatocytes at that time point. Later (30
and 60 min after CuSO4 addition), the
number of ATP7B-containing lysosomes
progressively increased, whereas theGolgi area gradually lost the ATP7B signal (Figure 2G), support-
ing the direct transfer of ATP7B from the TGN to the lysosomal
compartments.00, June 23, 2014 ª2014 The Authors 689
Figure 3. ATP7B Delivery to the Canalicular
Domain of Polarized HepG2 Cells Requires
a Lysosome Intermediate
(A) Polarized HepG2-MDR1 cells were fixed directly
after incubation with BCS or after additional treat-
ment with CuSO4 for either 2 hr or 8 hr. After incu-
bation with BCS, ATP7B was detected mainly
within Golgi membranes (red arrows) but neither in
CD63-positive lysosomes (blue arrows) nor in
canalicular vacuoles (green arrows). Exposure to
CuSO4 (2 hr) triggered ATP7B relocation to CD63-
positive structures (pink arrows), which were
frequently clustered around apical cysts (green
arrows). White arrows in the lower row show
canalicular vacuole, which received both ATP7B
and CD63 after 8 hr incubation with CuSO4.
(B) The percentage (mean ± SD; n = 20 fields) of
ATP7B-positive or CD63-positive canalicular vac-
uoles increased in HepG2 cells over the time of
incubation with CuSO4.
(C) The cells were treated like in (A) with the
exception that different CuSO4 concentrations
were utilized. The percentage (mean ± SD; n = 20
fields) of ATP7B-positive canalicular vacuoles was
calculated and plotted as a function of time.
(D) Polarized HepG2-MDR1 cells were with BCS
overnight or with CuSO4 for only 8 hr. The activity of
b-Gal (mean ± SD; n = 3 experiments) in the
canalicular cysts exhibits increase upon Cu stimu-
lation.
The scale bar represents 6.5 mm (A).
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ATP7B-Driven Lysosome Exocytosis in Cu HomeostasisWe next investigated which Golgi-to-lysosome pathway is
utilized by ATP7B. A large cohort of lysosomal proteins is carried
from the TGN to endolysosomal compartments through trans-
port events driven by clathrin and its adaptors, AP-1 and GGA
(Saftig and Klumperman, 2009), whereas other lysosome resi-
dents (such as LAMP1 and MHC-II) take a clathrin-independent
TGN-to-lysosome route (Pols et al., 2013; Saftig and Klumper-
man, 2009). We found that ATP7B did not associate with cla-
thrin-coated profiles (Figure 1F, arrowheads) in the TGN area
under neither low nor high Cu conditions. This is consistent
with recent observations that neither AP-1 nor GGA suppression
affects ATP7B export from the Golgi (Hirst et al., 2012). Further
examination revealed ATP7B enrichment over the smooth TGN
membrane domains (arrows in Figures 1F and 2H), which often
contained LAMP1 (Figure 2H, arrows). Shortly after Cu stimula-
tion, ATP7B was detected within 70–200 nm round or elongated
membrane carriers, which occasionally exhibited internal mem-
branes (Figure 2I, arrow) and therefore were similar to structures
operating in direct Golgi-to-lysosome transport of LAMP1 (Pols
et al., 2013). Indeed, these ATP7B carriers also frequently con-
tained LAMP1 and were docked to the MVB-like structures (Fig-
ure 2I), indicating that ATP7B and LAMP1 may use the same
pathway to travel from the TGN to lysosomal compartments.
ATP7B Is Delivered from Lysosomes to Canalicular PM
in Polarized Hepatocytes
ATP7B trafficking to lysosomes in response to Cu was unex-
pected and raised a question about the mechanism through
which the lysosomes mediate Cu excretion from hepatocytes.690 Developmental Cell 29, 686–700, June 23, 2014 ª2014 The AuthOne possibility would be that Cu efflux occurs through lysosomal
exocytosis, a mechanism by which lysosomes fuse with the PM
and secrete their content to the outside the cell (Andrews, 2000).
To examine whether ATP7B-containing lysosomes undergo
apical exocytosis, we grew HepG2 cells under conditions that
allowed for their polarization (Slimane et al., 2003). Upon polari-
zation, neighboring hepatocytes form an apical (or biliary) cyst
(vacuole) enriched in specific apical markers such as biliary
salt transporters MDR1, MRP2, etc. (Slimane et al., 2003). Polar-
ized HepG2 cells stably expressing canalicular marker MDR1-
GFP (Slimane et al., 2003) were incubated with BCS to trap
ATP7B within the Golgi and then exposed to 200 mM CuSO4 to
follow the fate of ATP7B. In low Cu, ATP7B was mostly detected
in the Golgi area (Figure 3A). Two hours after Cu stimulation,
ATP7B exhibited a significant overlap with CD63 in lysosomes,
which were frequently clustered around the biliary surface of
the cells (Figure 3A). Notably, over 40% of apical cysts already
exhibited ATP7B signal at this time point (Figure 3B). When
incubation with CuSO4 was extended to 8 hr, the ATP7B labeling
became more evident in canalicular cysts with 60% of them
being ATP7B positive (Figures 3A and 3B). We also found that
the redistribution of ATP7B to the canalicular domain of the
cells occurred even upon moderate Cu increase (20–40 mM)
and correlated with concentration of Cu and the duration
of CuSO4 treatment (Figure 3C). A lower concentration of
Cu (10 mM) was unable to induce ATP7B delivery to the canalic-
ular membrane of HepG2 cells, although it still allowed for effi-
cient ATP7B redistribution from the TGN to lysosomes (see
Figure 1E).ors
Figure 4. Activation of Lysosomal Exocy-
tosis Stimulates Delivery of ATP7B to the
Plasma Membrane
(A) HeLa or CF7 cells were infected with adeno-
ATP7B-GFP, incubated with CuSO4 for 2 hr, fixed,
and stained for LAMP1. Arrows indicate ATP7B in
lysosomes.
(B and C) HeLa (B) or CF7 cells (C) were treated as
in (A) and processed for immunogold EM to reveal
ATP7B-GFP distribution. In both cell types,
elevated Cu triggered ATP7B delivery to the
lysosome-like structures (B and C, arrows) and
plasma membrane (B and C, arrowhead).
(D) Morphometry revealed reduction of the dis-
tance (mean ± SD; n = 100 lysosomes) between
lysosomes and PM in CF7 cells.
(E) Arrowhead indicates the site of fusion between
ATP7B-positive lysosome (arrows) and PM in CF7
cell.
(F) Pie plots exhibit percentage of ATP7B-associ-
ated gold particles in different compartments of
HeLa and CF7 cells.
(G) HeLa and CF7 cells were infected with adeno-
ATP7B-GFP and then prepared for surface bio-
tinylation directly or 2 hr after stimulation with
200 mM CuSO4. Western blot revealed higher
amount of ATP7B at the surface of CF7 cells upon
Cu increase.
The scale bars represent 3.8 mm (A), 280 nm (B),
240 nm (C), and 220 nm (E).
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ATP7B-Driven Lysosome Exocytosis in Cu HomeostasisInterestingly, we also detected CD63 together with ATP7B in
the apical vacuoles upon Cu stimulation (Figures 3A and 3B).
This suggests that ATP7B and CD63 were delivered together
to the apical cysts of hepatocytes, likely through the induction
of lysosomal exocytosis in response to Cu stimulation. Indeed,
ATP7B delivery to the canalicular area of hepatocytes coincided
with an increase in activity of lysosomal enzyme b-galactosidase
(b-Gal) in biliary cysts upon Cu stimulation (Figure 3D).
Thus, apical lysosomal exocytosis may serve as a main route
for Cu excretion in hepatocytes because it allows for (1) release
of Cu from the ATP7B-positive lysosomal stores and (2) delivery
of ATP7B to the canalicular domain.
Modulation of Lysosomal Exocytosis Affects ATP7B
Delivery to the PM
Given that lysosomal exocytosis seems to be involved in the de-
livery of ATP7B to the cell surface, we decided to verify whether
modulation of this process impacts ATP7B trafficking to the PM.
To this end, we first used the CF7 HeLa cells that stably overex-Developmental Cell 29, 686–7press transcription factor EB (TFEB), a
potent activator of lysosomal exocytosis
(Medina et al., 2011). Stimulation with
CuSO4 induced ATP7B redistribution
from the Golgi to lysosomes and PM in
both CF7 and parental HeLa cells (Fig-
ure 4A). CF7 cells exhibited ATP7B in
numerous LAMP1-positive lysosomes
positioned close to the peripheral regions
of the cell membrane (Figure 4A). Such
LAMP1-positive structures constitute apool of peripheral lysosomes that actively undergo exocytosis
(Medina et al., 2011). Indeed, EM revealed ATP7B in lysosome-
like structures that were located significantly closer to the PM
in CF7 cells than in control HeLa cells (Figures 4B and 4C,
arrows, and 4D). Importantly, ATP7B-positive lysosomes were
frequently seen to fuse directly with the PM in CF7 cells (Fig-
ure 4E), resulting in increase in the amount of ATP7B compared
to the parental HeLa line (Figure 4F), as also confirmed by sur-
face biotinylation (Figure 4G). Taken together, these observa-
tions suggest that TFEB-mediated activation of lysosomal
exocytosis stimulates ATP7B delivery to the cell surface under
high Cu conditions.
To test whether this is also the case in a liver-relevant cell
system, polarized MDR1-GFP HepG2 cells were infected with
a helper-dependent adenovirus carrying TFEB DNA (HDAd-
TFEB) (Figures 5A–5D), which resulted in an increase in TFEB
expression (Figure 5C). TFEB- and mock-infected cells
were then exposed to CuSO4, and the ATP7B signal in MDR1-
GFP-positive biliary cysts was analyzed. We found that00, June 23, 2014 ª2014 The Authors 691
Figure 5. Modulation of Lysosomal Exocy-
tosis Impacts ATP7B Delivery to the Cana-
licular Domains of Hepatic Cells In Vitro
and In Vivo
(A) Polarized HepG2-MDR1 cells were infected
with HDAd-TFEB (middle column) or incubated
with MCOLN1-specific small interfering RNAs
(siRNAs) (right column) and exposed to 200 mM
CuSO4 for 8 hr. Immunofluorescent labeling
of endogenous ATP7B revealed increase in its
amount in the area of canalicular vacuoles (arrows
in the midcolumn) in the cells infected with HDAd-
TFEB and decrease in the canalicular area (arrows
in the right column) of MCOLN1-silenced cells.
(B) Quantification shows ATP7B-associated fluo-
rescence in the MDR1-positive canalicular vacu-
oles (mean ± SD; n = 50 canalicular vacuoles).
(C) qRT-PCR indicated increase in TFEB mRNA
levels in the cells infected with virus containing
TFEB DNA.
(D) Western blot revealed that total amounts of
endogenous ATP7B remained similar in control
and TFEB-overexpressing cells.
(E) qRT-PCR shows decrease in MCOLN1 mRNA
levels in MCOLN1-silenced cells.
(F and G) Liver tissue from the control and Tcfeb-
LiKO mice injected with adeno-ATP7B-GFP were
prepared for cryo-immuno-EM, which revealed
ATP7B (F, arrows) and LAMP1 (F, arrowheads) in
the canalicular region (F, asterisk) in control mice.
LAMP1 (G, arrowheads) and ATP7B (G, arrows)
exhibited poor signal at the canalicular membrane
(G, asterisk) in Tcfeb-LiKOmice but were detected
in neighbor lysosome (G, open arrow).
(H) ATP7B and LAMP1 labeling densities were
calculated in canalicular domains (mean ± SD; n =
50 canalicular areas) and in lysosomes (mean ±
SD; n = 50 lysosomes).
The scale bars represent 3.5 mm (A), 240 nm (F),
and 270 nm (G).
Developmental Cell
ATP7B-Driven Lysosome Exocytosis in Cu Homeostasisoverexpression of TFEB resulted in a higher amount of ATP7B
delivered to the apical domain of HepG2 cells (Figures 5A and
5B), whereas the total quantity of ATP7B remained the same
(Figure 5D).
In a parallel series of experiments, we inhibited lysosomal
exocytosis by suppressing mucolipin-1 (MCOLN1) using RNAi.
MCOLN1 is a Ca2+ channel, which promotes lysosome fusion
with PM (Medina et al., 2011). Reduction of MCOLN1 expression
in HepG2 cells (Figure 5E) resulted in a significant decrease in
ATP7B delivery to biliary surface (Figures 5A and B). Given that
Ca2+ is required for lysosomal exocytosis (Andrews, 2000), we
used the Ca2+ chelator BAPTA as another tool to inhibit lyso-
somal exocytosis and observed reduction in ATP7B trafficking
to the canalicular domain in BAPTA-treated cells (not shown).
Finally, we employed a mice model with a liver-specific
knockout of TFEB (Tcfeb-LiKO mice) (Settembre et al., 2013)
to evaluate whether inhibition of TFEB-mediated lysosomal
exocytosis affects delivery of ATP7B to the canalicular sites of
hepatocytes in vivo. To this end, control and Tcfeb-LiKO mice
were given Cu in their drinking water as described (Gross
et al., 1989). The mice were sacrificed 4 hr after stimulation
with Cu and their livers processed for analysis. EM revealed spe-
cific ATP7B and LAMP1 signals in canalicular area of hepato-692 Developmental Cell 29, 686–700, June 23, 2014 ª2014 The Authcytes in the liver of control mice (Figure 5F), indicating efficient
delivery of both proteins from the lysosomes upon Cu overload.
The presence of ATP7B and LAMP1 at the canalicular mem-
brane of hepatocytes correlated with increased activity of
b-Gal and b-hexosaminidase (b-Hex) in the bile (Figure S3A).
This suggests that Cu stimulates lysosomal exocytosis at the
biliary surface of hepatocytes and thus facilitates ATP7B delivery
from lysosomal structures to the canalicular membrane.
In contrast, TFEB deletion in the liver of Tcfeb-LiKO mice
resulted in significant reduction of both ATP7B and LAMP1
labeling at the biliary membrane of hepatocytes (Figures 5G
and 5H). We reasoned that the decrease of ATP7B at the
canalicular domains in Tcfeb-LiKO mice liver was due to the
suppression of lysosomal exocytosis. We found that ATP7B/
LAMP1-positive lysosomes can be detected near canaliculi (Fig-
ure 5G) in Tcfeb-LiKO mice and that ATP7B/LAMP1 labeling
densities in such lysosomes were similar to those in control
animals (Figure 5H). However, deletion of Tcfeb did not allow
ATP7B lysosomes to fuse with apical membrane of hepatocytes
and therefore to convey ATP7B to the canalicular surface. This
correlated with a significant reduction of b-Hex and b-Gal acti-
vities in the bile of Tcfeb-LiKO mice despite Cu stimulation
(Figure S3B).ors
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ATP7B-Driven Lysosome Exocytosis in Cu HomeostasisThus, taken together, both in vitro and in vivo observations
support the involvement of lysosomal exocytosis in targeting
ATP7B to the biliary surface domain in hepatic cells.
Activation of Lysosomal Exocytosis Increases Copper
Excretion from the Cells
To further test the impact of lysosomal exocytosis on Cu homeo-
stasis, we investigated whether this process is involved in the
regulation of Cu efflux from liver cells. Coppersensor 3 (CS3)
was employed to analyze intracellular levels of exchangeable
Cu (Dodani et al., 2011). Variations of intracellular Cu levels
observed in the control experiments with CS3 (Figures 6A and
6B) were confirmed by spectroscopy (Figure 6C).
Then, we investigated subcellular distribution of CS3 in cells
expressing ATP7B-GFP. HepG2 cells treated with BCS ex-
hibited low CS3 signal in the cytoplasm, whereas ATP7B-GFP
was mainly detected in the Golgi area (Figure 6D). Shortly
(15 min) after exposing cells to Cu, ATP7B appeared in the
lysosomes where increased CS3 signal was detected (Fig-
ure 6D). Longer incubation with CuSO4 (up to 2 hr) induced a
complete redistribution of ATP7B to the lysosomes (Figure 6D),
where CS3 fluorescence further concentrated, indicating that
ATP7B lysosomes could be used for temporary Cu storage/
sequestration.
Next, we reasoned that activation of lysosomal exocytosis
should allow reduction of intracellular Cu due to release of the
metal from the lysosome into canalicular vacuoles. To test this,
we used polarized HepG2 cells, which were infected with
HDAd-TFEB to activate lysosomal exocytosis, exposed to
CuSO4, and labeled with CS3. Confocal microscopy revealed
the CS3 signal to be higher in biliary cysts of TFEB-overexpress-
ing cells than in those of control cells (Figures 6E–6G). Mean-
while, CS3 fluorescence decreased in the cytoplasm of TFEB-
infected cells (Figure 6E). Elevation of Cu levels in the apical
vacuoles of TFEB-overexpressing HepG2 cells was confirmed
by inductively coupled plasma mass spectrometry (ICP-MS)
(Figure 6H), indicating that stimulation of lysosomal exocytosis
helps to excrete Cu from hepatocytes into biliary areas.
ATP7B Silencing Inhibits Apical Lysosomal Exocytosis,
Cu Excretion, and Polarization of Hepatic Cells
We then determined whether ATP7B is required for lysosome
exocytosis at the apical surface of hepatic cells. To this end, we
silenced ATP7B expression in polarized HepG2 cells (Figures
7A and 7B) and found that, in contrast to control cells, ATP7B-
deficient cells exhibited noCD63within canalicular domains (Fig-
ure7C, arrows). This finding suggests thatATP7Bpresence at the
lysosomesmight define their ability to undergo apical exocytosis.
Interestingly, ATP7Bablation also affected polarization of HepG2
cells, as we detected a reduction in the number of hepatocytes
making MDR1-positive canalicular cysts (Figures S4A, arrows,
and S4B) and a mistargeting of MDR1 to the basolateral surface
in silenced cells (Figures 7C, arrowheads, and S4A).
We also investigated the intracellular distribution of Cu in
ATP7B-deficient cells. We detected CS3 fluorescence within
the LAMP1-GFP-positive structures of control cells, whereas in
ATP7B-silenced cells, CS3 was hardly visible in LAMP1-GFP
spots (Figure 7D, arrows), indicating that lysosomes did not
receive Cu in the absence of ATP7B. Finally, we also foundDevelthat CS3 fluorescence in the canalicular area of ATP7B-deficient
HepG2 cells was lower than in control hepatocytes (Figure 7E,
arrows), whereas intracellular CS3 signal increased (Figures 7E
and 7F). Elevated intracellular Cu levels in ATP7B-silenced
HepG2 cells were also confirmed by ICP-MS (Figure 7G).
Taken together, these results indicate that ATP7B is involved
(1) in Cu import into lysosomes and (2) in apical exocytosis of
such lysosomes that allows elimination of excess Cu from the
cells and supports hepatocyte polarity.
Cu-Dependent Interaction with p62 Dynactin Subunit
Defines ATP7B Targeting to the Canalicular Surface of
Hepatic Cells
To understand the molecular mechanism through which ATP7B
targets lysosomes to the apical surface of hepatocytes, we
analyzed the publications on Cu-dependent protein interactions
of ATP7B. From this information, we found the interaction be-
tween ATP7B and the p62 subunit of dynactin (DNCT4) to be
particularly attractive from the trafficking standpoint (Lim et al.,
2006). Given that the minus ends of the microtubules are ori-
ented toward the canalicular domain of hepatocytes (Cohen
et al., 2004), the binding to p62 may allow ATP7B-containing
membranes to anchor the dynein motor and, therefore, be trans-
located to the biliary surface.
To test this hypothesis, we first immunoprecipitated endo-
genous p62 from either BCS- or CuSO4-treated HepG2 cells
and found significantly higher amounts of ATP7B in pull-downs
from the cells kept in high Cu (Figure 7H). Cu-dependent asso-
ciation of ATP7B with p62 was confirmed further using proximity
ligation assay (PLA) (D’Agostino et al., 2013). Figure 7I shows a
clear PLA signal, indicating close association between ATP7B
and p62 in cells that were exposed to CuSO4. Such PLA signal
was lacking in BCS-treated cells (Figure 7I), suggesting that
the effective interaction of ATP7B with p62 occurs only when
the intracellular Cu increases. We then analyzed the impact
of p62 silencing (Figure 7J) on Cu-dependent trafficking of
ATP7B. We found that p62 depletion did not affect ATP7B
transport from the Golgi to lysosomes upon increase in Cu con-
centration (Figure S4C). However, further clustering of ATP7B-
contaning lysosomes around the apical cyst and delivery of
ATP7B to the canalicular surface were seriously compromised
in p62-deficient HepG2 cells (Figure 7K, arrows). To further eval-
uate the impact of p62-ATP7B interaction on the lysosomal
exocytosis, we depleted p62 or ATP7B and measured the acti-
vity of lysosomal enzyme b-Gal within canalicular cysts of polar-
ized HepG2 cells stimulated with CuSO4. Both ATP7B-silenced
and p62-silenced cells exhibited significant reduction of enzyme
activities within the canalicular vacuoles (Figure 7L).
Notably, as it occurred in ATP7B-depleted cells, ablation of
p62 resulted in partial loss of polarity of HepG2 cells and partial
missorting of MDR1 from canalicular cysts (Figures 7K, arrow-
heads, S4D, and S4E). In contrast, the distribution of basolateral
markers such as E-cadherin and Na/K-ATPase remained intact
(Figure S4B) in silenced cells.
Taken together, these findings suggest (1) that the Cu-depen-
dent interaction between ATP7B and p62 is required for apical
exocytosis of ATP7B-positive lysosomes at the canalicular sur-
face of hepatocytes and (2) that this process contributes to the
polarization of HepG2 cells.opmental Cell 29, 686–700, June 23, 2014 ª2014 The Authors 693
Figure 6. Activation of Lysosomal Exocytosis Stimulates Cu Excretion from HepG2 Cells
(A) HepG2 cells were incubated with either 200 mMBCS or 200 mMCuSO4 for 2 hr loaded with CS3 for 15min before visualization at the confocal microscope. Cu-
associated CS3 signal was low in BCS-treated cells but significantly increased in Cu-loaded cells (see false color images of CS3 intensity in lower row).
(B) Quantification of the CS3 fluorescent intensity (mean ± SD; n = 15 fields) indicated its increase in CuSO4-treated cells.
(C) Cells were treated like in (A) and prepared for atomic adsorption spectroscopy (AAS) or inductively coupled plasma mass spectrometry (ICP-MS), which
revealed an increase in intracellular Cu concentration (mean ± SD; n = 4 experiments) in CuSO4-treated cells.
(D) HepG2 cells were infected with adeno-ATP7B-GFP, exposed to BCS, and observed in confocal microscope either directly or after 15 min or 2 hr incubation
with CuSO4. Insets show CS3 fluorescence within circular ATP7B lysosomes.
(E) Polarized HepG2-MDR1 cells were infected with HDAd-TFEB and then exposed to 200 mM CuSO4 for 8 hr and loaded with CS3.
(F) 3D plots show the intensity of the CS3 signal in the corresponding canalicular areas (dash line in D).
(G) Levels of CS3 fluorescence within canalicular cysts of HepG2 cells (mean ± SD; n = 100 cysts) increased in cells overexpressing TFEB.
(H) Polarized HepG2-MDR1 cells were infected with HDAs-TFEB and treated with CuSO4 as in (E). Afterward, canalicular cysts were opened with EDTA and
their content was analyzed for Cu using ICP-MS. Normalized Cu concentration (mean ± SD; n = 3 experiments) increased in the biliary cysts of cells over-
expressing TFEB.
The scale bars represent 7.5 mm (A) and 4 mm (D and E).
Developmental Cell
ATP7B-Driven Lysosome Exocytosis in Cu HomeostasisActivation of Lysosomal Exocytosis Accelerates Cell
Surface Delivery of the Most Frequent Wilson-Disease-
Causing ATP7B Mutant
Finally, we determined whether activation of lysosomal exocy-
tosis could be utilized as a therapeutic strategy to contrast694 Developmental Cell 29, 686–700, June 23, 2014 ª2014 The AuthWilson disease (WD) pathogenesis. The most frequent ATP7B
mutant H1069Q (up to 50% in Caucasian population; Payne
et al., 1998), exhibits residual catalytic activity (van den Berghe
et al., 2009) but is retained within the endoplasmic reticulum
(ER), where it undergoes degradation (Payne et al., 1998; vanors
Figure 7. ATP7B Regulates Lysosomal Exocytosis and Cu Excretion through Interaction with p62
(A) Western blot reveals reduction in ATP7B expression in HepG2-MDR1 incubated with ATP7B-specific siRNAs.
(B) qRT-PCR indicates reduction of ATP7B mRNA levels (mean ± SD; n = 3 experiments) in ATP7B-silenced cells.
(C) Polarized control and ATP7B-silenced HepG2-MDR1 cells were exposed to 200 mMCuSO4 for 8 hr, fixed, and stained for CD63. Arrows indicate apical cysts
whereas arrowheads show MDR1 mistargeting from the canalicular area.
(D) Control and ATP7B-silenced HepG2 cells were transfected with LAMP1-GFP, exposed to CuSO4, and loaded with CS3. Arrows indicate LAMP1-positive
structures.
(legend continued on next page)
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ATP7B-Driven Lysosome Exocytosis in Cu Homeostasisden Berghe et al., 2009). Thus, correction of this mutant to the
regular functional compartment might be beneficial for the large
cohort of the WD patients. Interestingly, despite extensive re-
tention within the ER (Figures 8A and 8B, arrows), some
ATP7BH1069Q gets transported to the Golgi (empty arrows in Fig-
ures 8A and 8B) and further to LAMP1-positive structures (Fig-
ure 8A, solid arrows). Thus, we reasoned that acceleration of
lysosomal exocytosis might allow a more-efficient supply of re-
sidual ATP7BH1069Q to the cell surface, where it can transport
Cu out of the cell. To test this, TFEB-overexpressing CF7 cells
were infected with an adenovirus carrying ATP7BH1069Q and
exposed to CuSO4. Arrows in Figure 8A show that exocytosis-
prone lysosomes, which reside near the surface of CF7 cells
(Medina et al., 2011), received ATP7BH1069Q. This coincided
with a stronger immunogold labeling of the mutant protein at
the surface of CF7 cells compared to the parental HeLa line
(Figures 8B, arrowheads, and 8C). Correspondingly, a bio-
tinylation assay revealed a significant increase in the amount of
ATP7BH1069Q at the surface of CF7 cells (Figure 8D). Therefore,
activation of lysosomal exocytosis allowed recovery of addi-
tional quantities of ATP7BH1069Q at the cell surface.
To verify this conclusion in a liver-relevant system, polarized
HepG2 cells expressing ATP7BH1069Q were infected with
HDAd-TFEB and exposed to CuSO4 for 8 hr. Confocal micro-
scopy revealed that, in control cells, ATP7BH1069Q was hardly
detectable within the MRP2-positive canalicular cysts, whereas
overexpression of TFEB stimulated delivery of themutant ATP7B
toward the canalicular domain of hepatocytes (Figure 8E,
arrows). Therefore, activation of lysosomal exocytosis allows re-
covery of additional amounts of ATP7BH1069Q at the cell surface.
DISCUSSION
Our findings indicate that exposure of hepatocytes to increasing
Cu concentrations induces ATP7B trafficking from the TGN to
subset of lysosomes, where ATP7B imports Cu into the lyso-
somal lumen and where the metal can be transiently stored.
Further Cu increase over a threshold value (approximately
20 mM) induces the exocytosis of lysosomes containing ATP7B
with subsequent delivery of the Cu transporter to the apical
surface of hepatocytes and the release of Cu into the biliary
space. Importantly, ATP7B determines both the ability of the
lysosome to undergo exocytosis and also the apical/canalicular
direction of the exocytic process. Apparently, exocytosis is trig-(E) Control and ATP7B-silenced HepG2-MDR1 cells were treated with 200 mM C
vacuoles.
(F) Ratio between intracellular and canalicular CS3 fluorescence (mean ± SD; n =
(G) Cells were treated like in (E) and prepared for ICP-MS, which revealed an inc
ATP7B depletion.
(H) HepG2 cells were infected with adeno-ATP7B-GFP, exposed to BCS and or
Western blot reveals that similar amount of p62 pulls down higher amount of AT
(I) The cells were infected and treated like in (A) and processed for PLA analysis (se
and p62 was detectable as red spots (arrows) only in CuSO4-treated cells.
(J) Western blot and qRT-PCR indicate reduction of p62 at both protein and mR
(K) Control and p62-silenced polarized HepG2-MDR1 cells were exposed to CuSO
Empty arrowheads indicate MDR1 mistargeting from the canalicular area.
(L) Control, p62-silenced, or ATP7B-silenced HepG2 cells were exposed to CuSO
n = 3 experiments) in the canalicular cysts upon depletion of either p62 or ATP7B
The scale bars represent 4 mm (C–E), 3 mm (I), and 5.2 mm (K).
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which allows ATP7B to anchor lysosomes on microtubule high-
ways directed toward the apical pole of hepatocytes. In our
view, this sequence of events outlines the main mechanism,
which is utilized by hepatocytes to remove excess Cu from liver
and which is affected by ATP7B mutations in Wilson disease.
Some signs of this mechanism were uncovered more than 20
years ago when lysosomes were suggested to operate in Cu
homeostasis (Gross et al., 1989). Later, ATP7B was even de-
tected in late endosomes (Harada et al., 2000, 2005), and its
involvement in the secretion of some lysosomal enzymes into
bile was reported (Sugawara et al., 1995). Unfortunately, the
conclusive experiments that would directly demonstrate a role
of lysosomal exocytosis in ATP7B trafficking, molecular mecha-
nisms behind this process, and its coordination with Cu excre-
tion were not performed. Therefore, above findings remained
mostly neglected over the last decade. This happened mainly
because ATP7B trafficking and compartmentalization, which
constitutes the centerpiece of Cu homeostasis in liver, remained
poorly understood and highly controversial (La Fontaine and
Mercer, 2007; Polishchuk and Lutsenko, 2013). The major mys-
tery in the field was the nature of so-called ‘‘vesicles,’’ where
ATP7B resides in high-Cu conditions and how such vesicles
operate in Cu excretion.
In this study, identification of the ATP7B transport itinerary
allowed us to close these gaps and to complete the puzzle of
the mechanism at the basis of Cu excretion in hepatocytes.
Our initial finding revealed a subpopulation of lysosomes as
the main intermediate in ATP7B trafficking. We demonstrated
lysosomes to receive ATP7B directly from the TGN in response
to increasing Cu and to actively use this pump for Cu import.
This allowed us to assign the elusive ‘‘vesicular’’ ATP7B
compartment with identity of the lysosomes.
The lysosomal localization of ATP7B in high Cu conditions
raises several issues regarding the ATP7B-dependent mecha-
nisms of Cu homeostasis. The first is whether Cu is required in
the lysosome or it is merely sequestered there. Cu in lysosomes
can be utilized as a cofactor by housekeeping enzymes (acid
sphingomyelinase) (Qiu et al., 2003). Interestingly, another Cu
pump, ATP7A, supplies the metal in a similar way to tyrosinase
across the membrane of lysosome-related organelles melano-
somes (Setty et al., 2008). ATP7A was also found to transport
Cu into LAMP1/Rab7-positive phagosomes of macrophages,
where the metal has been hypothesized to kill engulfed bacteriauSO4 for 8 hr and loaded with CS3. Arrows show MDR1-positive canalicular
100 cells) increased in ATP7B-deficient cells.
rease in normalized Cu concentration (average ± SD; n = 4 experiments) upon
CuSO4, lysed, and subjected to immunoprecipitation with anti-p62 antibody.
P7B in CuSO4-treated cells.
e Experimental Procedures). PLA signal indicating close association of ATP7B
NA levels in HepG2-MDR1 cells incubated with p62-specific siRNAs.
4, fixed, and stained for endogenous ATP7B. Arrows indicate canalicular cysts.
4 for 8 hr. The chart shows decrease of normalized activity of b-Gal (mean ± SD;
.
ors
Figure 8. Activation of Lysosomal Exocytosis Improves Delivery of Most-Frequent WD-Causing ATP7BH1069Q Mutant to the Cell Surface
(A) Control HeLa cells and CF7 cells were infected with adeno-ATP7BH1069Q-GFP, incubated with 200 mM CuSO4 for 2 hr, and stained for LAMP1 and TGN 46.
Open and solid arrows show Golgi and lysosomes, respectively.
(B) Control HeLa and CF7 cells were treated as in (A), fixed, and processed for immunogold EM to reveal ATP7BH1069Q distribution. Although ATP7BH1069Q was
mistargeted to the ER (arrows), it can be detected also in theGolgi (empty arrow) and lysosomes (empty arrowheads). Filled arrowheads indicate higher amount of
ATP7BH1069Q at the surface of CF7 cells.
(C) Quantification revealed increase in the percentage of ATP7B-associated gold particles (average ± SD; n = 30 cells) at the plasma membrane in CF7 cells.
(legend continued on next page)
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ATP7B-Driven Lysosome Exocytosis in Cu Homeostasis(White et al., 2009). Thus, the ability to reach the lysosomal
compartment and to function there could be a common feature
of both Cu ATPases. Importantly, low pH in the lysosomes
does not inhibit metal-transporting activity of ATP7B but favors
it (Safaei et al., 2008).
The second issue is whether liver lysosomes may operate as
Cu storage compartments. Our data suggest that lysosomes
can uptake excessCu from the cytosol throughATP7B (Figure 6),
whereas the release of Cu in the opposite direction could occur
through the lysosome-targeted Cu channel CTR2 (van den
Berghe et al., 2007) when this metal is needed in the cytosol.
We found that, at the Cu concentrations below 20 mM, ATP7B
reaches the lysosomes from the TGN, but these lysosomes do
not undergo exocytosis unless Cu levels increase further. This
probably allows the ATP7B lysosomes to transiently store Cu,
when its concentration does not yet threat cell homeostasis.
Therefore, Cu fluxes to and from the lysosomes and, hence,
Cu storage in these organelles should be tightly regulated.
Indeed, yeast cells utilize vacuole (lysosome analog) for Cu
storage (Nevitt et al., 2012), indicating that this function of lyso-
somes is conserved in evolution.
The third issue is whether an ATP7B-positive subset of lyso-
somes resembles lysosome-related organelles (LROs), which
discharge their content in response to specific stimuli (Raposo
et al., 2007). This property may be required for rapid release of
Cu from the lysosome lumen into the bile in response to Cu
overload. However, we found that neither Rab27A nor VAMP7
nor synaptotagmin7 depletion affected exocytosis of ATP7B-
positive structures (Figure S5). Thus, in terms of exocytosis,
ATP7B-positive lysosomes do not resemble LROs,which require
Rab27A (Raposo et al., 2007). On the other hand, ATP7B-
positive lysosomes share only some common elements of the
exocytic molecular machinery (Ca2+ and MCOLN1) with com-
mon lysosomes, which need VAMP7 and synaptotagmin7 for
exocytosis. In our view, the lysosomes may require a specific
and unique asset of molecules for apical exocytosis in hepato-
cytes. ATP7B itself may be a part of such specific machinery,
as it is expressed almost exclusively in hepatic cells (Lutsenko
et al., 2007).
In this context, another significant finding of our study indi-
cates lysosomal exocytosis to operate for both ATP7B and Cu
delivery to the biliary surface of hepatocytes. Lysosomal exocy-
tosis plays a major role in several physiological processes such
as cellular immune response, bone resorption, and PM repair
(Andrews, 2000). Our in vitro and in vivo data suggest that stim-
ulation of lysosomal exocytosis increases both ATP7B and Cu in
biliary cysts. Thus, it turns out that exocytosis of the lysosomes
allows hepatocytes to expel sequestered Cu and to deliver
ATP7B to canalicular surface, where it might pump Cu directly
from the cytosol into the bile (Hubbard and Braiterman, 2008).
Our discovery of the ATP7B trafficking mechanism poses new
questions. The first question addresses the way in which Cu trig-
gers exocytosis of the lysosomes that receive ATP7B. We found(D) HeLa and CF7 cells were infected with adeno-ATP7BH1069Q-GFP and then p
CuSO4. Western blot revealed higher amount of ATP7B at the surface of CF7 ce
(E) Polarized HepG2 cells expressing ATP7BH1069Q-GFP were infected with HDA
marker MRP2. Arrows indicate canalicular cyst.
The scale bars represent 3.8 mm (A), 240 nm (B), and 6.5 mm (E).
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of lysosomal content at the biliary surface (Figures 7C and 7L). In
line with these observations, ATP7B-deficient rats exhibit signif-
icant decrease of lysosome enzyme activity in the bile (Sugawara
et al., 1995), presumably due to suppression of lysosomal exocy-
tosis in the absence of functional ATP7B. Thus, the presence of
ATP7B probably defines whether a given lysosome has to un-
dergo exocytosis in hepatocytes when Cu increases. Moreover,
ATP7B also determines the apical/canalicular direction of such
exocytosis. We found that the ability of ATP7B to drive exocytic
processes in response to Cu is likely governed by ATP7B’s inter-
action with the p62. p62 interacts with ATP7B in the presence of
high Cu (Lim et al., 2006; see also Figures 7H and 7I) and there-
fore, being in complex with dynactin and dynein motor, can
probably pull ATP7B-enriched lysosomes to the microtubule
minus ends, which are oriented toward the canalicular domain
of hepatocytes (Cohen et al., 2004). Indeed, we observed that
depletion of p62 does not allow ATP7B-containing lysosomes
to move toward the apical pole of HepG2 cells and to deliver
ATP7B to the canalicular surface, even in the presence of excess
Cu (see Figure 7). These findings are in line with previous studies
showing microtubule disruption to impair delivery of ATP7B to
the canalicular surface of HepG2 cells (Roelofsen et al., 2000).
Our observations also indicate that ATP7B-mediated lysosomal
exocytosis may contribute to polarization of hepatic cells (Fig-
ure S4), likely facilitating the delivery of specific proteins and
lipids to the apical membrane domain. Partial disorganization
of liver architecture and hepatic tumor development in ATP7B-
deficient mice (Huster et al., 2006) argues in favor of this
hypothesis.
The second question is whether and how the lysosome exo-
cytosis pathway may be utilized for therapeutic purposes. Stim-
ulation of lysosomal exocytosis via TFEB overexpression has
already been shown to promote cellular clearance in lysosomal
storage diseases (Medina et al., 2011). Here, we found that
transcriptional activation of lysosomal exocytosis allows partial
recovery of the proper subcellular localization of the most
frequent WD-causing mutant to the regular ATP7B functional
site. Given that this mutant possesses significant residual Cu-
transporting activity (van den Berghe et al., 2009), its rescue to
the correct location on the biliary surface of hepatocytes could
be beneficial for a large cohort of WD patients. On the other
hand, toxic Cu accumulation in lysosomes has been reported
during pathogenesis of choleostatic disorders (Gross et al.,
1989) and could be probably circumvented (contrasted) through
activation of the lysosome fusion with the cell membrane. In
addition, the well-known role of ATP7B in Wilson disease has
been recently expanded to its involvement in other pathologies
such as modulation of the Alzheimer’s disease phenotype and
anticancer drug resistance (Gupta and Lutsenko, 2009). Thus,
the ATP7B-dependent lysosomal exocytosis emerges as a
promising therapeutic target to combat WD and a number of
other disorders.repared for surface biotinylation directly or 2 hr after stimulation with 200 mM
lls.
d-TFEB, incubated with 200 mM CuSO4 for 8 hr, and stained with canalicular
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Cell Culture and Transfection and Construction of Recombinant
Adenoviruses
HepG2, HepG2-MDR1, HeLa, and HeLa CF7 cells were grown in Dulbecco’s
modified Eagle’smedium supplemented with 10% fetal calf serum (decomple-
mented for HepG2), 2mM L-glutamine, penicillin, and streptomycin. For trans-
fection of plasmids, jetPEI TM-Hepatocyte (Polyplus transfection) and Trans IT
LT1 (TemaRicerca SRL) transfection reagents were used for HepG2 andHeLa,
respectively.
Trafficking Assay and Cu Treatment
To investigate localization of ATP7B at the different Cu load, cells were treated
with 200 mM Cu-chelating agent BCS and with different concentrations of
CuSO4. To compare trafficking of ATP7B with VSVG, cells were incubated
with BCS (overnight), then infected with VSV (Polishchuk et al., 2003), incu-
bated at 20C in the presence of BCS (to accumulate both proteins in the
Golgi), and finally warmed to 32C and treated with CuSO4 (to activate post-
Golgi transport of both proteins). Tannic acid (0.5%) was added in some exper-
iments during release of 20C block to inhibit fusion of post-Golgi transport
carriers with the PM (Polishchuk et al., 2004).
Mice and Treatment
Two-month-old males of Tcfeb-flox mouse (Settembre et al., 2013) were used.
TcFEB loxP/loxPmice that did not carry the albumin Crewere utilized as a con-
trol. To express ATP7B-GFP, mice were subjected to retro-orbital injection
with adeno-ATP7B-GFP 3 days before the experiment. To stimulate Cu excre-
tion from liver, both control and Tcfeb-flox mice received 0.125% CuSO4 in
water 4 hr before the animals were sacrificed (Gross et al., 1989). Liver tissue
was rapidly dissected from the mice, fixed, and processed for electron micro-
scopy, whereas bile was collected from gall bladder for b-Gal and b-Hex
assays. All experiments were approved by the Committee on Animal Care at
Baylor College of Medicine and conform to the legal mandates and federal
guidelines for the care and maintenance of laboratory animals.
Immunofluorescence and CS3 Labeling
Cells were fixed for 10 min with 4% paraformaldehyde in 0.2 M HEPES, per-
meabilized, labeled with primary and secondary antibodies, and examined
with a ZEISS LSM 700 or LSM 710 confocal microscope equipped with a
633 1.4 numerical aperture oil objective. For fluorescent Cu detection, cells
were incubated with 5 mM CS3 solution for 15 min at 37C. CS3 was excited
with 561 nm laser of LSM710, and its emission was collected from 565 to
650 nm. Colocalization module of ZEISS ZEN 2008 software was used to
measure colocalization of ATP7B with different intracellular markers. ATP7B
fluorescent signal inside canalicular domains and CS3 cytosolic and canalic-
ular surface signals were measured using ZEISS ZEN 2008 software and re-
ported in arbitrary units.
Immunoelectron Microscopy
For pre-embedding immunoelectron microscopy, cells were fixed, per-
meabilized, and labeled as described previously (Polishchuk et al., 2003).
For cryo-immunoelectron microscopy, specimens were fixed, frozen, and
cut using Leica EM FC7 ultramicrotome. Cryo sections were double labeled
for LAMP1 and GFP. EM images were acquired using a FEI Tecnai-12 electron
microscope. Morphometric analyses were performed using iTEM software
(Olympus SIS).
Statistical Analyses
Data are expressed as mean values ± SD. Statistical significance was
computed using the Student’s two-tail t test. A p value < 0.05 was considered
statistically significant. In all figures, *p < 0.05, **p < 0.01, and ***p < 0.001.
Additional Methods
Additional information on DNA constructs, adenoviruses, antibodies, immuno-
precipitation, surface biotinylation, PLA, quantitative RT-PCR (qRT-PCR),
RNAi, determination of b-Gal and b-Hex activities, atomic adsorption spec-
troscopy (AAS), and ICP-MS is provided in the Supplemental Experimental
Procedures.DevelSUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and five figures and can be found with this article online at http://dx.doi.org/
10.1016/j.devcel.2014.04.033.
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